Article
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
PloS one - 1 Jan 2022
Dosoo David Kwame, Bailey Jeffrey A, Asante Kwaku Poku, Oppong Felix Boakye, Niaré Karamoko, Opoku-Mensah Jones, Owusu-Agyei Seth, Greenwood Brian, Chandramohan Daniel
Abstract excerpt
Intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) is used to prevent malaria and associated unfavorable maternal and foetal outcomes in pregnancy in moderate to high malaria transmission areas. Effectiveness of IPTp-SP is, however, threatened by mutations in the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes which confer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
